Home > Qtrly Results > BLISS GVS PHARMA

BLISS GVS PHARMA
Quarterly Results Analysis [Sep2025]

AD     Remove this Ad

BLISS GVS PHARMA Quarterly Results

Consolidated Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
Audited
Jun2024
Audited
Mar2024
UnAudited
Dec2023
UnAudited
Revenues ₹244 Cr ₹207 Cr ₹198 Cr ₹210 Cr ₹218 Cr ₹184 Cr ₹198 Cr ₹201 Cr
Expenses ₹213 Cr ₹166 Cr ₹177 Cr ₹181 Cr ₹178 Cr ₹149 Cr ₹170 Cr ₹157 Cr
Operating Income ₹32 Cr ₹41 Cr ₹21 Cr ₹30 Cr ₹40 Cr ₹34 Cr ₹28 Cr ₹44 Cr
Other Income ₹20 Cr ₹35 Cr ₹12 Cr ₹15 Cr ₹7 Cr ₹4 Cr ₹6 Cr ₹5 Cr
Interest ₹3 Cr ₹5 Cr ₹2 Cr ₹1 Cr ₹4 Cr ₹2 Cr ₹2 Cr ₹2 Cr
Depreciation ₹8 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹7 Cr ₹7 Cr ₹7 Cr ₹7 Cr
Profit Before Tax ₹41 Cr ₹63 Cr ₹23 Cr ₹36 Cr ₹36 Cr ₹30 Cr ₹-4 Cr ₹40 Cr
Profit After Tax ₹29 Cr ₹44 Cr ₹17 Cr ₹26 Cr ₹26 Cr ₹22 Cr ₹-5 Cr ₹29 Cr
EPS ₹2.58 ₹4.08 ₹1.47 ₹2.26 ₹2.31 ₹1.97 ₹-0.87 ₹2.64
Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA 9.2% 8.9% 13.2%
SUN PHARMACEUTICAL INDUSTRIES -2.3% -7.3% -12.8%
DIVIS LABORATORIES 0.8% -5.8% 4.7%
CIPLA 0.7% -11.2% -6.5%
TORRENT PHARMACEUTICALS 0.8% 3.7% 20.8%
DR REDDYS LABORATORIES -1.4% -3.8% -1.3%
MANKIND PHARMA 1.1% -1.3% -16.1%
ZYDUS LIFESCIENCES 0.4% -1.8% -6.9%
LUPIN 0.7% 3.4% -0.1%

BLISS GVS PHARMA Quarterly Revenues

Revenues
Q-o-Q

17.80 %

Y-o-Y

12.27 %

Quarters Revenues % Change
Sep2025 ₹244 Cr
17.80
Jun2025 ₹207 Cr
4.79
Mar2025 ₹198 Cr
-5.91
Dec2024 ₹210 Cr
-3.34
Sep2024 ₹218 Cr
18.53
Jun2024 ₹184 Cr
-7.31
Mar2024 ₹198 Cr
-1.29
Dec2023 ₹201 Cr -

BLISS GVS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-23.16 %

Y-o-Y

-20.09 %

Quarters Operating Profit % Change
Sep2025 ₹32 Cr
-23.16
Jun2025 ₹41 Cr
96.01
Mar2025 ₹21 Cr
-29.22
Dec2024 ₹30 Cr
-25.04
Sep2024 ₹40 Cr
15.75
Jun2024 ₹34 Cr
21.11
Mar2024 ₹28 Cr
-35.12
Dec2023 ₹44 Cr -
Operating Margins
Q-o-Q

-34.79 %

Y-o-Y

-28.86 %

Quarters Operating Margin% % Change
Sep2025 12.99%
-34.79
Jun2025 19.92%
87.04
Mar2025 10.65%
-24.79
Dec2024 14.16%
-22.45
Sep2024 18.26%
-2.30
Jun2024 18.69%
30.61
Mar2024 14.31%
-34.27
Dec2023 21.77% -

BLISS GVS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-35.55 %

Y-o-Y

11.27 %

Quarters Profit After Tax % Change
Sep2025 ₹29 Cr
-35.55
Jun2025 ₹44 Cr
166.40
Mar2025 ₹17 Cr
-35.46
Dec2024 ₹26 Cr
0.42
Sep2024 ₹26 Cr
16.22
Jun2024 ₹22 Cr
Positive
Mar2024 ₹-5 Cr
Negative
Dec2023 ₹29 Cr -
PAT Margins
Q-o-Q

-45.28 %

Y-o-Y

-0.85 %

Quarters PAT Margin(%) % Change
Sep2025 11.7 %
-45.28
Jun2025 21.38 %
154.22
Mar2025 8.41 %
-31.40
Dec2024 12.26 %
3.90
Sep2024 11.8 %
-1.99
Jun2024 12.04 %
Positive
Mar2024 -2.48 %
Negative
Dec2023 14.48 % -

BLISS GVS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-36.76 %

Y-o-Y

11.69 %

Quarters EPS % Change
Sep2025 ₹2.58
-36.76
Jun2025 ₹4.08
177.55
Mar2025 ₹1.47
-34.96
Dec2024 ₹2.26
-2.16
Sep2024 ₹2.31
17.26
Jun2024 ₹1.97
Positive
Mar2024 ₹-0.87
Negative
Dec2023 ₹2.64 -

You may also like the below Video Courses